Genpharmasec Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Genpharmasec Ltd. on BSE

Load latest

Genpharmasec Ltd.

14 Nov 2022

1.99

1.02%

Company Update

Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Extract of Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2022, as published in Active Times [English Version] on 12th November, 2022 and in Mumbai Lakshadeep [Marathi Version] on 13th November, 2022

pdf

Genpharmasec Ltd.

14 Nov 2022

1.99

1.02%

Company Update

Genpharmasec Ltd - 531592 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held On …

BSE India

This is in continuation of the outcome of Financial results submitted by the company on 11th Nov, 2022 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting Conclusion time was inadvertently not mentioned. We are hereby submitting a revised outcome of Board Meeting for approval of Financial results having the required information i.e the Conclusion Time as specified to be given under SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015, and there is no change in any financial figures.

pdf

Genpharmasec Ltd.

14 Nov 2022

1.99

1.02%

Result

Genpharmasec Ltd - 531592 - Results- Financial Results For Half Year 30Th September,2022

BSE India

pdf

Genpharmasec Ltd.

11 Nov 2022

1.99

1.02%

Result

Genpharmasec Ltd - 531592 - Results- Financial Statement For Half Year September''2022

BSE India

Pursuant to the provisions of Regulation 30 (2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your good self that the Board of Directors of our Company in their meeting held on Friday, 11th November, 2022 at 03.00 p.m. has Considered and Approved the following: 1. Considered and Approved and taken on records the Un-Audited Financial Results along with Cash flow statement and Limited Review Report for the quarter and half year ended 30th September, 2022 prepared in terms of IND-AS, pursuant to Regulation 33 of (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Considered and Approved and taken on records the Unaudited Statement of Assets and Liabilities for the half year ended 30th September, 2022.

pdf

Genpharmasec Ltd.

11 Nov 2022

1.99

1.02%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, …

BSE India

1. Considered and Approved and taken on records the Un-Audited Financial Results along with Cash flow statement and Limited Review Report for the quarter and half year ended 30th September, 2022 prepared in terms of IND-AS, pursuant to Regulation 33 of (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Considered and Approved and taken on records the Unaudited Statement of Assets and Liabilities for the half year ended 30th September, 2022

pdf

Genpharmasec Ltd.

03 Nov 2022

1.99

1.02%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter & …

BSE India

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve 1. To Consider & approve the Un-Audited Financial Results along with the Limited Review Report for the Quarter & half year ended on September 30, 2022 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Consider and Approve the Un-audited Statement of Assets and Liabilities for the half year ended 30th September, 2022. 3. Any other business matter with the permission of the Chair.

pdf

Genpharmasec Ltd.

02 Nov 2022

1.99

1.02%

Company Update

Genpharmasec Ltd - 531592 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that SEBI has passed an Order dated 28th October, 2022 against Satellite Corporate Services Pvt. Ltd., Registrar and Share Transfer agent of our Company under Regulation 27 of the SEBI (Intermediaries) Regulation, 2008 which is enclosed herewith for your easy reference. As per the said SEBI order dated 28th October, 2022 the Certificate of Registration of Satellite Corporate Services Pvt. Ltd. has been Suspended for a period of 3 months. The suspension of Certificate of Registration will take effect immediately on the expiry of 21 days from the date of the order. Accordingly, SEBI has advised the Client companies to conduct their own independent due diligence/audit of Satellite Corporate Services Pvt. Ltd. and Satisfy themselves about the capabilities of Satellite Corporate Services Pvt. Ltd. to continue their RTA activities.

pdf

Genpharmasec Ltd.

01 Nov 2022

1.99

1.02%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of Board Meeting And Disclosures Under …

BSE India

Pursuant to Regulation 30 read with Schedule III of SEBI and all other applicable provisions, if any, of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015 ("Listing Regulations"), we would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 01st November, 2022 have considered and accepted the resolutions given under below attched PDF.

pdf

Genpharmasec Ltd.

27 Oct 2022

1.99

1.02%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Appointment Of Independent Directors And CFO

BSE India

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2022 ,inter alia, to consider and approve 1. Appointment of Independent Directors (Additional) 2. Resignation of Chief Financial Officer (CFO) 3. Appointment of new CFO 4. Any other business with the permission of the Chairperson

pdf

Genpharmasec Ltd.

11 Oct 2022

1.99

1.02%

Company Update

Genpharmasec Ltd - 531592 - Disclosure Required Under Part A Schedule (3)- Resignation Of Independent Director.

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we would like to inform you that the Board of Directors have considered, accepted and passed the resolution by circular motion on Tuesday 11th October, 2022, thereby accepting Ms. Amisha Dani's resignation from the post of Non-executive Independent Director of our Company. We are enclosing her resignation letter with reasons for her resignation, for your perusal and records.

pdf

Is Generic Pharmasec Ltd. worth buying?

106 Votes:

Buy 83.02%

Sell 7.55%

Hold 9.43%